...
首页> 外文期刊>Biochemistry and Biophysics Reports >Investigation of the antimicrobial activity of soy peptides by developing a high throughput drug screening assay
【24h】

Investigation of the antimicrobial activity of soy peptides by developing a high throughput drug screening assay

机译:通过开发高通量药物筛选试验研究大豆肽的抗菌活性

获取原文
           

摘要

Background Antimicrobial resistance is a great concern in the medical community, as well as food industry. Soy peptides were tested against bacterial biofilms for their antimicrobial activity. A high throughput drug screening assay was developed using microfluidic technology, RAMAN spectroscopy, and optical microscopy for rapid screening of antimicrobials and rapid identification of pathogens. Methods Synthesized PGTAVFK and IKAFKEATKVDKVVVLWTA soy peptides were tested against Pseudomonas aeruginosa and Listeria monocytogenes using a microdilution assay. Microfluidic technology in combination with Surface Enhanced RAMAN Spectroscopy (SERS) and optical microscopy was used for rapid screening of soy peptides, pathogen identification, and to visualize the impact of selected peptides. Results The PGTAVFK peptide did not significantly affect P. aeruginosa , although it had an inhibitory effect on L. monocytogenes above a concentration of 625 μM. IKAFKEATKVDKVVVLWTA was effective against both P. aeruginosa and L. monocytogenes above a concentration of 37.2 μM. High throughput drug screening assays were able to reduce the screening and bacterial detection time to 4 h. SERS spectra was used to distinguish the two bacterial species. Conclusions PGTAVFK and IKAFKEATKVDKVVVLWTA soy peptides showed antimicrobial activity against P. aeruginosa and L. monocytogenes . Development of high throughput assays could streamline the drug screening and bacterial detection process. General significance The results of this study show that the antimicrobial properties, biocompatibility, and biodegradability of soy peptides could possibly make them an alternative to the ineffective antimicrobials and antibiotics currently used in the food and medical fields. High throughput drug screening assays could help hasten pre-clinical trials in the medical field. Highlights ? Soy peptide PGTAVFK above 312.5 μM concentrations inhibits Listeria monocytogenes . ? IKAFKEATKVDKVVVLWTA restricts motility and aggregation of Listeria monocytogenes. ? Microfluidic 3D device generate multiplex parallel drug concentration gradients. ? RAMAN spectroscopy microfluidics provides a high throughput drug-screening assay.
机译:背景技术抗菌素耐药性在医学界以及食品工业中是一个高度关注的问题。测试了大豆肽对细菌生物膜的抗菌活性。使用微流技术,RAMAN光谱学和光学显微镜开发了一种高通量药物筛选测定方法,用于快速筛选抗菌剂和快速鉴定病原体。方法用微量稀释法检测合成的PGTAVFK和IKAFKEATKVDKVVVLWTA大豆肽对铜绿假单胞菌和单核细胞增生性李斯特菌。微流体技术与表面增强拉曼光谱(SERS)和光学显微镜相结合,可用于大豆肽的快速筛选,病原体鉴定以及可视化所选肽的影响。结果PGTAVFK肽虽然对625μM以上的浓度对单核细胞增生李斯特菌具有抑制作用,但对铜绿假单胞菌没有明显影响。 IKAFKEATKVDKVVVLWTA对浓度高于37.2μM的铜绿假单胞菌和单核细胞增生李斯特菌均有效。高通量药物筛选测定能够将筛选和细菌检测时间减少到4小时。 SERS光谱用于区分两种细菌。结论PGTAVFK和IKAFKEATKVDKVVVLWTA大豆肽对铜绿假单胞菌和单核细胞增生李斯特菌具有抗菌活性。高通量检测方法的开发可以简化药物筛选和细菌检测过程。总体意义这项研究的结果表明,大豆肽的抗菌特性,生物相容性和生物降解性可能使它们成为食品和医学领域目前使用的无效抗菌剂和抗生素的替代品。高通量药物筛选测定可以帮助加快医学领域的临床前试验。强调 ?高于312.5μM的大豆肽PGTAVFK抑制单核细胞增生性李斯特菌。 ? IKAFKEATKVDKVVVLWTA会限制李斯特菌的运动和聚集。 ?微流体3D设备生成多重并行药物浓度梯度。 ? RAMAN光谱微流控技术提供了高通量的药物筛选测定方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号